Penumbra
PEN
#1825
Rank
S$12.14 B
Marketcap
$316.47
Share price
-2.42%
Change (1 day)
11.45%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Penumbra (PEN) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : S$0.50 Billion

According to Penumbra's latest financial reports the company's total liabilities are S$0.50 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Penumbra - Total liabilities on balance sheet (from 2014 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$0.49 B-0.07%
2022-12-31S$0.49 B27.07%
2021-12-31S$0.39 B60.2%
2020-12-31S$0.24 B0.8%
2019-12-31S$0.24 B92.15%
2018-12-31S$0.12 B24.02%
2017-12-31S$0.10 B68.97%
2016-12-31S$60.36 M36.22%
2015-12-31S$44.31 M-74.93%
2014-12-31S$0.17 B76.1%
2013-12-31S$0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$0.35 B-29.98%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.41 B 181.37%๐Ÿ‡บ๐Ÿ‡ธ USA